Registered number
11521126
Ram Medical Consultancy Limited
Filleted Accounts
31 March 2025
Ram Medical Consultancy Limited
Registered number: 11521126
Balance Sheet
as at 31 March 2025
Notes 2025 2024
£ £
Current assets
Investments held as current assets 3 596,581 673,921
Cash at bank and in hand 33,442 34,242
630,023 708,163
Creditors: amounts falling due within one year 4 (1,493) (1,673)
Net current assets 628,530 706,490
Total assets less current liabilities 628,530 706,490
Net assets 628,530 706,490
Capital and reserves
Called up share capital 2 2
Profit and loss account 628,528 706,488
Shareholders' funds 628,530 706,490
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Dr A Goel
Director
Approved by the board on 16 September 2025
Ram Medical Consultancy Limited
Notes to the Accounts
for the period from 1 September 2024 to 31 March 2025
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2 Employees 2025 2024
Number Number
Average number of persons employed by the company 0 0
3 Investments held as current assets 2025 2024
£ £
Fair value
Listed investments 596,581 673,921
596,581 673,921
Increase/(decrease) in fair value included in the profit and loss account for the period
Listed investments (57,770) 123,567
(57,770) 123,567
4 Creditors: amounts falling due within one year 2025 2024
£ £
Taxation and social security costs 191 392
Other creditors 1,302 1,281
1,493 1,673
5 Controlling party
The company is under the control of Dr A Goel and Mrs L Goel.
6 Other information
Ram Medical Consultancy Limited is a private company limited by shares and incorporated in England. Its registered office is:
37 Grove Park
London
E11 2DN
Ram Medical Consultancy Limited 11521126 false 2024-09-01 2025-03-31 2025-03-31 VT Final Accounts April 2025 Dr A Goel No description of principal activity 11521126 2023-09-01 2024-08-31 11521126 core:WithinOneYear 2024-08-31 11521126 core:ShareCapital 2024-08-31 11521126 core:RetainedEarningsAccumulatedLosses 2024-08-31 11521126 2024-09-01 2025-03-31 11521126 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-03-31 11521126 bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-03-31 11521126 bus:Director40 2024-09-01 2025-03-31 11521126 1 2024-09-01 2025-03-31 11521126 2 2024-09-01 2025-03-31 11521126 countries:England 2024-09-01 2025-03-31 11521126 bus:FRS102 2024-09-01 2025-03-31 11521126 bus:FilletedAccounts 2024-09-01 2025-03-31 11521126 2025-03-31 11521126 core:WithinOneYear 2025-03-31 11521126 core:ShareCapital 2025-03-31 11521126 core:RetainedEarningsAccumulatedLosses 2025-03-31 11521126 2024-08-31 iso4217:GBP xbrli:pure